Navigation Links
New MedPredict Report Highlights Recent Advances in Management of Malignant Hematology
Date:1/15/2010

SCOTTSDALE, Ariz., Jan. 15 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.  These reports are based on primary interviews conducted with hematologists from North America immediately following the American Society of Hematology (ASH) annual meeting.

This report, entitled "Thought Leader Insight & Analysis – Malignant Hematology," includes analysis of new research in Multiple Myeloma, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, Lymphoma, and Chronic Myelogenous Leukemia.  

"This report reflects on and analyzes the most important data presented at ASH, and clarifies the ways these data will change clinical practice," according to Jeff Berk, MedPredict president. "A key focus of the report is Multiple Myeloma (MM), which is being transformed into a chronic, but still life threatening disease.  The most exciting advances presented at ASH included both identifying the most effective combinations for induction therapy, and in establishing a role and practice standard for maintenance therapy in MM."

According to one MM Thought Leader interviewed for this report:  "I think the message was very positive in regards that maintenance matters, choice of induction strategy matters with less toxicity being important, and staying on treatment of some form or another is very critical."

The expert panel also discusses novel compounds in development for various hematologic malignancies, and the hurdles they will need to overcome to become viable options in this market.  

Companies and partnerships mentioned in this report i
'/>"/>

SOURCE MedPredict
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Landscape for Lung Cancer Therapies is Focus of New Post-ASCO MedPredict Report
2. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
3. New Report by BioTrends Research Group To Highlight The Launch Of ACTEMRA (tocilizumab)
4. Does the MS Market Need Another Interferon? Neurologists Provide Insight in the Wave One Report of LaunchTrends: EXTAVIA
5. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
6. BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties
7. Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
8. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
9. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
10. Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
11. Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will attend The Benchmark Company, LLC,s Micro Cap ... will be held at The Palmer House Hilton, 17 E. ... a.m. to 2:30 p.m. Please email hska@haydenir.com or ...
(Date:11/26/2014)... BOCA RATON, Fla. , Nov. 25, 2014 ... has entered into a multi-product ANDA agreement with ... Maryland ) under which Breckenridge and Pii ...  Under the terms of the agreement, Pii will ... will market and distribute the products under its ...
(Date:11/26/2014)... and HERZLIYA PITUACH, Israel, Nov. 25, 2014 ... or "the Company"), a clinical stage biopharmaceutical company ... targeted therapeutics for the treatment of inflammatory diseases ... previously announced underwritten public offering of 3,450,000 units, ... the Company,s common stock, par value $0.0001 per ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) ... 31, 2011. "We are pleased to have completed ... the FDA this year to reach agreement on the protocol ... treatment of sickle cell crisis," said Brian M. Culley, Chief ...
... CYPRESS, Calif., May 9, 2011 Medison and Samsung ... Medison. The combined company, a joint partnership between Korea,s ... world,s largest and most technologically-advanced electronics and consumer goods ... into a global leader in medical device industry. ...
Cached Medicine Technology:ADVENTRX Reports First Quarter 2011 Financial Results 2ADVENTRX Reports First Quarter 2011 Financial Results 3ADVENTRX Reports First Quarter 2011 Financial Results 4ADVENTRX Reports First Quarter 2011 Financial Results 5Samsung Medison Pledges to Become a World-Class Medical Device Company 2
(Date:11/27/2014)... Luciana Lagana and her husband ... Omadox, a feature film that received 9 awards at the ... ensemble cast. It is also an official selection of the ... a successful cinematic career for James Noel, a young filmmaker ... enjoy experimental mystery, filmed in glorious black and white, watching ...
(Date:11/27/2014)... 27, 2014 Blood-borne pathogens raise the ... precautions and procedures in place to counter this. However, ... of things tainted with menstrual blood are taken as ... simpler, more sanitary way to handle tampons and menstrual ... from Sonora, Calif. , He then created a prototype ...
(Date:11/27/2014)... 27, 2014 Nearly 1,100 Risperdal ... in a consolidated litigation now underway in Pennsylvania ... Documents recently updated in the Philadelphia Court of ... state proceeding, all of which involve a drug ... psychiatric conditions. Many of the cases in this ...
(Date:11/27/2014)... By Dennis Thompson ... -- An experimental Ebola vaccine appears to be safe and ... the deadly virus, according to early clinical trial results reported ... of the phase I clinical trial for the vaccine paves ... nations of Liberia and Sierra Leone as early as January, ...
(Date:11/27/2014)... The founders of VIM & VIGR, a ... functioning compression socks, are proud to announce the debut of ... Gradient Pressure (TM) knitting technology that is designed to increase ... commitment to adding flair and style to a product that ... the eye of a writer at The New York ...
Breaking Medicine News(10 mins):Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2
... BERKELEY, CA An $18 million, three-year grant to ... cancer was awarded today to a multi-institutional "Dream Team" ... Gray, a renowned cancer researcher with the U.S. Department ... was awarded by Stand Up To Cancer, an Entertainment ...
... Virtual Event for Research Scientists, Engineers and Professionals Slated for ... Abstracts(at)BioConferenceLive.com , ... Boston, MA (PRWEB) ... media company that produces online events for the healthcare, education ...
... of Insomnia and Potential Solutions NEW YORK, May 27 ... Center for Medicine in the Public Interest (CMPI), has ... and treatment of insomnia translates to billions of dollars ... CMPI also estimates insomnia is responsible for at ...
... suggests what to include in a Pet Evacuation KitSAN ANTONIO, ... 1 and is expected to bring 12 named storms, with ... pets to evacuate or take shelter against these devastating storms ... www.purinacare.com ) suggests preparing a Pet Evacuation ...
... Effectiveness of Managing Data Systems Delivery [While Providing ... SunGard Availability Services has partnered with Phoenix ... outsourcing, consulting and revenue cycle management solutions, to ... records (EMR) and other technologies essential to quality ...
... ban on direct-to-consumer drug advertising and has exposed Canadians ... those for drugs with life-threatening risks, according to a ... and James M. Wright from UBC,s Centre for Health ... drugs from 1995 to 2006 and saw spending rise ...
Cached Medicine News:Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 2Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 3Health News:PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community 2Health News:PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community 3Health News:Ignoring Insomnia Costs America $42 Billion a Year 2Health News:Ignoring Insomnia Costs America $42 Billion a Year 3Health News:Keep Your Pets Safe in a Hurricane 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 3Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 4Health News:Legal loophole exposes Canadians to drug advertising banned in US: UBC research 2